openPR Logo
Press release

HPV Vaccines Market Insights by Size, Status and Forecast 2024

07-06-2018 08:22 AM CET | Health & Medicine

Press release from: Transparency Market Research

HPV Vaccines Market Insights by Size, Status and Forecast 2024

Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.

More than 40 types of HPV viruses are easily transferred from one person to another by sexual contact anal and oral. It has estimated worldwide prevalence of HPV induced cancer in approximately 12-13%. Cervical cancer is the second largest cause of cancer deaths in women worldwide. According to World Health Organization it has been estimated that globally 510,000 cases per year and about 288,000 deaths occur due to cervical cancer.

Obtain Report Details @ https://www.transparencymarketresearch.com/hpv-therapeutic-vaccines.html

Currently, three U.S. FDA approved vaccines are commercially available namely Gardasil, Gardasil 9 (Merck & Co., Inc.) and Cervarix (GlaxoSmithKline Pharmaceuticals Ltd.) for the prevention from HPV infections. The HPV vaccines market is at a nascent stage and it would take approximately couple of decades to implement mass vaccination for preventing cervical cancer incidences.

Gardasil is a quadrivalent vaccine and targets four HPV types (6, 11, 16 and 18) while Cervarix is bivalent vaccine and targets on two HPV types (16 and 18). It has been observed that neither of these HPV vaccines have been proven to provide complete protection against tenacious infections with other types of HPVs. GARDASIL 9 is a vaccine indicated in females 9 through 26 years of age for the prevention of cervical, vulvar, vaginal, and anal cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58; precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and 11. GARDASIL 9 is indicated in males 9 through 26 years of age for the prevention of anal cancer caused by HPV Types 16, 18, 31, 33, 45, 52, and 58; precancerous or dysplastic lesions caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58; and genital warts caused by HPV Types 6 and 11.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1936

HPV vaccines market is the most potential market as the annual worldwide incidences for cervical cancer is almost 0.5 million and for cancers of vulva and vagina its 40,000. In addition, to this annual incidence for high-grade cervical intraepithelial neoplasia (CIN) the precancerous condition of cervical cancer is almost 0.5 million globally. Thus, according to International Agency for Research and Cancer predicts the rate of HPV related cancer cases to rise 40% in near future. North America and Europe are major markets as the governments from major countries of these regions have publicly funded HPV vaccination.

Some of the market players in this industry segment are Merck& Co., Inc. and GlaxoSmithKline Pharmaceuticals Ltd. While, ISA Pharmaceuticals (ISA101), Advaxis (Lovaxcin C), Coridon(It is funded by Allied Healthcare Group for HPV associated research) and Gentical (which is currently in the Phase III clinicaltrial)and all these products are in pipeline.

Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1936

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HPV Vaccines Market Insights by Size, Status and Forecast 2024 here

News-ID: 1112754 • Views: 198

More Releases from Transparency Market Research

Polyethylene Pipes & Fittings Market Trends, Forecast 2030
Polyethylene Pipes & Fittings Market: Introduction In terms of value, the global polyethylene pipes & fittings market is expected to reach ~US$ 20 Bn by 2030, expanding at a CAGR of ~6% during the forecast period. Rise in demand for polyethylene pipes and fittings in various applications such as water supply, oil & gas supply, and agricultural water supply is a key factor driving the global polyethylene pipes & fittings market.
Balsa Core Materials Market for Structural Composites Forecast to 2030
Balsa Core Materials Market for Structural Composites: Introduction In terms of value, the global balsa core materials market for structural composites is anticipated to expand at a CAGR of ~5% from 2020 to 2030. Balsa is used as a core material, owing to its excellent chemical and styrene resistance, as well as neutral behavior. It can be processed with various different resin systems. Furthermore, it offers excellent laminate adhesion properties. End-grain
Trending : Blood Pressure Monitoring Devices & Accessories Market Companies to G …
Transparency Market Research (TMR) has published a new report titled, ‘Plasma Protein Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22,413.9 Mn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027. Overview Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique,
Analysis of Potential Impact of COVID-19 on Plasma Protein Therapeutics Market …
Transparency Market Research (TMR) has published a new report titled, ‘Plasma Protein Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22,413.9 Mn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027. Overview Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique,

All 5 Releases


More Releases for HPV

Cytology and HPV Testing Market - Research Analysis
The nature of the both the markets for cytology testing and HPV or human papillomavirus testing is oligopolistic in nature, states Transparency Market Research (TMR) in a research report. With the presence of only a handful of leading companies in the market, the competition is not that high as they compete among themselves with different or almost similar strategies. These few players are currently enjoying their reign in the global
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017
"The Report Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape. Human papillomavirus (HPV) is the most common viral infection
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,
HPV Testing Market 2017- Qiagen, Roche Diagnostics, Hologic
HPV Testing Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. “The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing,
New Research: Global Human Papillomavirus (HPV) Market
MarketResearchReports.Biz presents this most up-to-date research on "Human Papillomavirus (HPV)- Epidemiology Forecast To 2023" Latest Report, Human Papillomavirus (HPV) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Human Papillomavirus (HPV) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Human Papillomavirus (HPV) prevalent or incident cases segmented by age, sex and subpopulations. The
Cytology And HPV Testing Market : Early Detection Of Cervical Cancer Using Cytol …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. Cytology and HPV testing kits are used extensively in PAP testing and cervical cancer testing. This report on the cytology and HPV testing